Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Your Representatives on Capitol Hill

Jane Jerrard  |  Issue: March 2007  |  March 1, 2007

The ACR also lobbies for increased funding for the Veterans Administration and the Agency for Healthcare Research and Quality (AHRQ). “There are lots of other places we want to see increased funding for research,” says Dr. Flood.

The committee advocates for Medicare reform, including the simplification and re-evaluation of the prescription drug plan. “Part D benefits apply to our treatments, and we want to make sure that our patients are covered for those treatments,” says Dr. Flood. “Most of our patients fall into the donut hole. We also support the off-label use of drugs when it’s worthwhile. When pharmacy or insurance representatives make decisions, they want cost-only use of meds; we know what’s best for our patients.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The committee continues to fight for a reversal of Medicare reimbursement cuts to both the technical and the professional components of dual-energy absorptiometry (DXA) testing of bone mineral density (BMD). “I don’t think the government really wants to prevent early warnings of fracture risk, but the overall costs to CMS of imaging went up 28% last year,” says Dr. Flood. “CMS is rightfully concerned about this, but I think we unfairly got swept up in their desire to cut back.

“We want to take the BMD issue head on,” he continues. “First, we’ll start a public relations campaign, perhaps including volunteer organizations concerned with osteoporosis. Second, we’d like to appeal to CMS at a higher level. Ideally, we’d like to have a meeting with the administrator.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Flood and his committee members also keep an eye on quality-of-care issues such as pay-for-performance. “We believe those [measures] ought to include our input,” explains Dr. Flood. “The ACR has put together a starter set of 16 quality indicators….Any kind of performance indicators should be relevant and no further burden of time” to busy rheumatologists.

Arthritis Bill Highlights

If it becomes law, the Arthritis Prevention, Control, and Cure Act will support arthritis research and education. Here are some highlights from the bill.

  • Enhance the National Arthritis Action Plan;
  • Develop a National Arthritis Education and Outreach Campaign;
  • Organize a National Arthritis and Rheumatic Diseases Summit;
  • Support juvenile arthritis research; and
  • Encourage health professionals to enter the field of pediatric rheumatology.

2007 Budget and Legislative Issues

Most recently, the ACR added its voice to other organizations that insisted on restoring continued funding to the Centers for Disease Control lupus registry that collects data and provides a basis for future research. “We were successful,” says Dr. Flood. “The government re-instituted funds for that, and the research is continuing.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:Legislation & AdvocacyProfessional Topics Tagged with:AC&RAdvocacyCongressLegislationRegulationRheumatic Disease

Related Articles

    Food Lover Dr. Joseph Flood Discusses Cooking, Shares Recipe

    June 21, 2018

    In addition to the classroom and exam room, the other room Joseph Flood, MD, enjoys spending time in is the kitchen. With a mother who worked as a local tavern cook and a policeman father who enjoyed preparing tasty meals as much as arresting bad guys, Dr. Flood, a rheumatologist at the Columbus Arthritis Center…

    PAC Progress and Challenges

    November 1, 2009

    After three years, RheumPAC has a solid start, and more work ahead of it

    Rheumatology Goes to Washington

    May 1, 2007

    Volunteers converge on Capitol Hill for the ACR’s annual Advocates for Arthritis Day

    Update on Legislation, Advocacy Efforts to Advance Rheumatology

    September 1, 2014

    Status of progess to fix sustainable growth rate physician formula, other rheumatology-related issues facing Congress

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences